Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
48.66
+0.60 (1.25%)
At close: Mar 5, 2026, 4:00 PM EST
48.23
-0.43 (-0.88%)
After-hours: Mar 5, 2026, 6:24 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 |
|---|
| 376.57M | 312.97M | 245.11M | 203.57M | 132.33M | | | | | |
Synthetic DNA Products Growth | 20.32% | 27.69% | 20.41% | 53.83% | 46.87% | | | | | |
| 376.57M | 312.97M | 245.11M | 203.57M | 132.33M | | | | | |
| 20.32% | 27.69% | 20.41% | 53.83% | 46.87% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 |
|---|
| 225.58M | 193.88M | 151.26M | 122.47M | 77.91M | | | | | |
| 16.35% | 28.18% | 23.51% | 57.20% | 31.68% | | | | | |
Europe, Middle East and Africa (EMEA) | 124.24M | 92.57M | 71.39M | 62.08M | 44.12M | | | | | |
Europe, Middle East and Africa (EMEA) Growth | 34.22% | 29.67% | 15.00% | 40.69% | 70.88% | | | | | |
| 26.75M | 26.52M | 22.46M | 19.01M | 10.30M | | | | | |
Asia Pacific (APAC) Growth | 0.86% | 18.11% | 18.11% | 84.60% | 101.37% | | | | | |
| 376.57M | 312.97M | 245.11M | 203.57M | 132.33M | | | | | |
| 20.32% | 27.69% | 20.41% | 53.83% | 46.87% | | | | | |
Source: S&P Global Market Intelligence.